NP
Nilsine Partners’s Eli Lilly LLY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.47M | Sell |
12,153
-35
| -0.3% | -$27.3K | 0.96% | 22 |
|
2025
Q1 | $10.1M | Buy |
12,188
+272
| +2% | +$225K | 1.1% | 18 |
|
2024
Q4 | $9.2M | Buy |
11,916
+600
| +5% | +$463K | 0.98% | 19 |
|
2024
Q3 | $10M | Sell |
11,316
-78
| -0.7% | -$69.1K | 1.3% | 16 |
|
2024
Q2 | $10.3M | Buy |
11,394
+17
| +0.1% | +$15.4K | 1.38% | 15 |
|
2024
Q1 | $8.85M | Buy |
11,377
+812
| +8% | +$632K | 1.21% | 19 |
|
2023
Q4 | $6.16M | Buy |
10,565
+241
| +2% | +$140K | 0.95% | 25 |
|
2023
Q3 | $5.55M | Sell |
10,324
-142
| -1% | -$76.3K | 0.84% | 27 |
|
2023
Q2 | $4.91M | Hold |
10,466
| – | – | 0.72% | 33 |
|
2023
Q1 | $3.59M | Buy |
+10,466
| New | +$3.59M | 0.56% | 50 |
|